Case Report

Delirium and tremor associated with ertapenem treatment

Volume: 57 Number: 1 March 1, 2018
EN TR

Delirium and tremor associated with ertapenem treatment

Abstract

Though seizures are the most commonly reported neurotoxic adverse effects of ertapenem, there are numerous other side effects including hallucinations, disorientation, and tremors which are hardly ever reported. These side effects can be life-threatening, in the case of continued use of ertapenem. However, these treatment-related side effects completely resolve with discontinuation of the treatment. A 60-year-old female patient underwent hemodialysis owing to acute kidney insufficiency. Ertapenem was used to treat the condition since cultures from blood and urine sample of the patient showed growth of extended-spectrum beta-lactamase positive Escherichia coli. It was seen that the patient experienced tremors in the hand on the sixth day of the treatment, and hallucinations, disorientation, aggression, impaired speech as well as gait disturbances on the eighth day. With the discontinuation of ertapenem treatment, all these symptoms disappeared within 72 hours. This paper emphasizes on the neurotoxicity other than seizures resulting from ertapenem.

Keywords

References

  1. Oo Y, Packham D, Yau W, Munckhof WJ. Ertapenem‐associated psychosis and encephalopathy. Int Med J 2014:44(8);817-9.
  2. Apodaca K, Baker, Bin-Bilal H, Raskin Y, Quinn DK. Ertapenem-induced delirium: A case report and literature review. Psychosomatics 2015:56(5);561-6.
  3. Ribo FZ, Ribo AA. Ertapenem-induced neuropsychiatric symptoms in an elderly patient with chronic kidney disease resulting to a prescribing cascade. J Pharmacovigil 2014;2(6):152.
  4. Duquaine S, Kitchell E, Tate T, Tannen RC, Wickremasinghe IM. Central nervous system toxicity associated with ertapenem use. Ann Pharmacother 2011:45(1):e6.
  5. Veillette JJ, Van Epps P. Ertapenem-induced hallucinations and delirium in an elderly patient. Consult Pharm 2016:31(4);207-14.
  6. Lee KH, Ueng YF, Wu CW, Chou YC, Ng YY, Yang WC. The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients–case reports and literature reviews. J Clin Pharm Ther 2015:40(2); 240-4.
  7. Shea YF, Mok MYM, Cheng KC, Hon FKS, Chu LW. Delayed recovery from ertapenem induced encephalopathy: Case report and a possible mechanism. Int J Clin Pharm 2013:35(4);535-7.
  8. Kong V, Beckert L, Awunor-Renner C. A case of beta lactam–induced visual hallucination. N Z Med J 2009;122(1298):76-7.

Details

Primary Language

English

Subjects

-

Journal Section

Case Report

Authors

Fatih Temoçin
0000-0002-4819-8242
Türkiye

Publication Date

March 1, 2018

Submission Date

February 19, 2017

Acceptance Date

April 24, 2017

Published in Issue

Year 1970 Volume: 57 Number: 1

Vancouver
1.Hatice Köse, Fatih Temoçin. Delirium and tremor associated with ertapenem treatment. EJM. 2018 Mar. 1;57(1):60-3. doi:10.19161/etd.414446

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.